129 related articles for article (PubMed ID: 29122359)
1. Prognostic impact of RITA expression in patients with anal squamous cell carcinoma treated with chemoradiotherapy.
Rödel F; Steinhäuser K; Kreis NN; Friemel A; Martin D; Wieland U; Rave-Fränk M; Balermpas P; Fokas E; Louwen F; Rödel C; Yuan J
Radiother Oncol; 2018 Feb; 126(2):214-221. PubMed ID: 29122359
[TBL] [Abstract][Full Text] [Related]
2. Polo-like kinase 3 and phosphoT273 caspase-8 are associated with improved local tumor control and survival in patients with anal carcinoma treated with concomitant chemoradiotherapy.
Rödel F; Martin D; Helmke C; Balermpas P; Fokas E; Wieland U; Rave-Fränk M; Kitz J; Matthess Y; Raab M; Strebhardt K; Rödel C
Oncotarget; 2016 Aug; 7(33):53339-53349. PubMed ID: 27462786
[TBL] [Abstract][Full Text] [Related]
3. Human papillomavirus DNA load and p16INK4a expression predict for local control in patients with anal squamous cell carcinoma treated with chemoradiotherapy.
Rödel F; Wieland U; Fraunholz I; Kitz J; Rave-Fränk M; Wolff HA; Weiss C; Wirtz R; Balermpas P; Fokas E; Rödel C
Int J Cancer; 2015 Jan; 136(2):278-88. PubMed ID: 24839133
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of human papillomavirus in anal squamous cell carcinoma.
Ravenda PS; Magni E; Botteri E; Manzotti M; Barberis M; Vacirca D; Trovato CM; Dell'Acqua V; Leonardi MC; Sideri M; Fazio N; Zampino MG
Cancer Chemother Pharmacol; 2014 Nov; 74(5):1033-8. PubMed ID: 25209946
[TBL] [Abstract][Full Text] [Related]
5. The prognostic significance of tumor human papillomavirus status for patients with anal squamous cell carcinoma treated with combined chemoradiotherapy.
Yhim HY; Lee NR; Song EK; Kwak JY; Lee ST; Kim JH; Kim JS; Park HS; Chung IJ; Shim HJ; Hwang JE; Kim HR; Nam TK; Park MR; Shim H; Park HS; Kim HS; Yim CY
Int J Cancer; 2011 Oct; 129(7):1752-60. PubMed ID: 21128253
[TBL] [Abstract][Full Text] [Related]
6. External validation of leukocytosis and neutrophilia as a prognostic marker in anal carcinoma treated with definitive chemoradiation.
Schernberg A; Huguet F; Moureau-Zabotto L; Chargari C; Rivin Del Campo E; Schlienger M; Escande A; Touboul E; Deutsch E
Radiother Oncol; 2017 Jul; 124(1):110-117. PubMed ID: 28662871
[TBL] [Abstract][Full Text] [Related]
7. Chemoradiotherapy for squamous cell anal carcinoma: a review of prognostic factors.
Kapacee ZA; Susnerwala S; Wise M; Biswas A; Danwata F; Scott N
Colorectal Dis; 2016 Nov; 18(11):1080-1086. PubMed ID: 27028038
[TBL] [Abstract][Full Text] [Related]
8. Prognostic Relevance of HPV Infection and p16 Overexpression in Squamous Cell Anal Cancer.
Mai S; Welzel G; Ottstadt M; Lohr F; Severa S; Prigge ES; Wentzensen N; Trunk MJ; Wenz F; von Knebel-Doeberitz M; Reuschenbach M
Int J Radiat Oncol Biol Phys; 2015 Nov; 93(4):819-27. PubMed ID: 26530750
[TBL] [Abstract][Full Text] [Related]
9. Epidermal growth factor receptor expression as prognostic marker in patients with anal carcinoma treated with concurrent chemoradiation therapy.
Fraunholz I; Rödel F; Kohler D; Diallo-Georgiopoulou M; Distel L; Falk S; Rödel C
Int J Radiat Oncol Biol Phys; 2013 Aug; 86(5):901-7. PubMed ID: 23755922
[TBL] [Abstract][Full Text] [Related]
10. CD8+ tumour-infiltrating lymphocytes in relation to HPV status and clinical outcome in patients with head and neck cancer after postoperative chemoradiotherapy: A multicentre study of the German cancer consortium radiation oncology group (DKTK-ROG).
Balermpas P; Rödel F; Rödel C; Krause M; Linge A; Lohaus F; Baumann M; Tinhofer I; Budach V; Gkika E; Stuschke M; Avlar M; Grosu AL; Abdollahi A; Debus J; Bayer C; Stangl S; Belka C; Pigorsch S; Multhoff G; Combs SE; Mönnich D; Zips D; Fokas E
Int J Cancer; 2016 Jan; 138(1):171-81. PubMed ID: 26178914
[TBL] [Abstract][Full Text] [Related]
11. A Systematic Review and Meta-Analysis of Prognostic Biomarkers in Anal Squamous Cell Carcinoma Treated With Primary Chemoradiotherapy.
Parwaiz I; MacCabe TA; Thomas MG; Messenger DE
Clin Oncol (R Coll Radiol); 2019 Dec; 31(12):e1-e13. PubMed ID: 31301958
[TBL] [Abstract][Full Text] [Related]
12. Squamous cell carcinoma antigen: a potentially useful prognostic marker in squamous cell carcinoma of the anal canal and margin.
Williams M; Swampillai A; Osborne M; Mawdsley S; Hughes R; Harrison M; Harvey R; Glynne-Jones R;
Cancer; 2013 Jul; 119(13):2391-8. PubMed ID: 23576077
[TBL] [Abstract][Full Text] [Related]
13. Tumour-infiltrating lymphocyte scores effectively stratify outcomes over and above p16 post chemo-radiotherapy in anal cancer.
Gilbert DC; Serup-Hansen E; Linnemann D; Høgdall E; Bailey C; Summers J; Havsteen H; Thomas GJ
Br J Cancer; 2016 Jan; 114(2):134-7. PubMed ID: 26730577
[TBL] [Abstract][Full Text] [Related]
14. Neutrophil:lymphocyte ratio as a simple and novel biomarker for prediction of locoregional recurrence after chemoradiotherapy for squamous cell carcinoma of the anus.
Toh E; Wilson J; Sebag-Montefiore D; Botterill I
Colorectal Dis; 2014 Mar; 16(3):O90-7. PubMed ID: 24148256
[TBL] [Abstract][Full Text] [Related]
15. HPV positive, wild type TP53, and p16 overexpression correlate with the absence of residual tumors after chemoradiotherapy in anal squamous cell carcinoma.
Soares PC; Abdelhay ES; Thuler LCS; Soares BM; Demachki S; Ferro GVR; Assumpção PP; Lamarão LM; Ribeiro Pinto LF; Burbano RMR
BMC Gastroenterol; 2018 Feb; 18(1):30. PubMed ID: 29466950
[TBL] [Abstract][Full Text] [Related]
16. Impact of tobacco smoking on the patient's outcome after (chemo)radiotherapy for anal cancer.
Lerman J; Hennequin C; Etienney I; Abramowitz L; Goujon G; Gornet JM; Guillerm S; Aparicio T; Valverde A; Cattan P; Quéro L
Eur J Cancer; 2020 Dec; 141():143-151. PubMed ID: 33137590
[TBL] [Abstract][Full Text] [Related]
17. The PD-1/PD-L1 axis and human papilloma virus in patients with head and neck cancer after adjuvant chemoradiotherapy: A multicentre study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG).
Balermpas P; Rödel F; Krause M; Linge A; Lohaus F; Baumann M; Tinhofer I; Budach V; Sak A; Stuschke M; Gkika E; Grosu AL; Abdollahi A; Debus J; Stangl S; Ganswindt U; Belka C; Pigorsch S; Multhoff G; Combs SE; Welz S; Zips D; Lim SY; Rödel C; Fokas E;
Int J Cancer; 2017 Aug; 141(3):594-603. PubMed ID: 28480996
[TBL] [Abstract][Full Text] [Related]
18. Concomitant chemoradiotherapy with Cisplatin plus 5-Fluorouracil for anal squamous cell carcinoma.
El-Hadaad HA; Wahba HA; Roshdy S
J Gastrointest Cancer; 2015 Jun; 46(2):156-60. PubMed ID: 25810165
[TBL] [Abstract][Full Text] [Related]
19. A novel biomarker-based analysis reliably predicts nodal metastases in anal carcinoma: preliminary evidence of therapeutic impact.
Mistrangelo M; Senetta R; Racca P; Castellano I; Chiusa L; Bellò M; Ricardi U; Morino M; Cassoni P
Colorectal Dis; 2013 Nov; 15(11):1382-91. PubMed ID: 23692332
[TBL] [Abstract][Full Text] [Related]
20. Influence of human papillomavirus and p16(INK4a) on treatment outcome of patients with anal cancer.
Koerber SA; Schoneweg C; Slynko A; Krug D; Haefner MF; Herfarth K; Debus J; Sterzing F; von Knebel Doeberitz M; Prigge ES; Reuschenbach M
Radiother Oncol; 2014 Dec; 113(3):331-6. PubMed ID: 25465729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
